Junzhi Wang - Concepedia

Author

Junzhi Wang

National Institutes for Food and Drug Control ORCID

Also Known As

J Wang, J Z Wang, J-Z Wang, J. Wang, J. Z. Wang, J.-Z. Wang, JUNZHI WANG, Jun Zhi Wang, Jun-Zhi Wang, Jun-zhi WANG

446

Publications

8.7K

Citations

H-Index

161

Concepts

All Affiliations

National Institutes for Food and Drug Control Health Canada Sinovac Biotech Air Force Medical University Jiangsu Provincial Center for Disease Control and Prevention

About

Junzhi Wang is an author at National Institutes for Food and Drug Control specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	68	4.1K
2	Natural Sciences	8	8	439
3	Engineering	6	6	174
4	Public Health	2	2	280
5	Social Sciences	1	1	12

Junzhi Wang

131

Publications

7.4K

Citations

H-Index

Page 1

	Year	Citations
Efficacy, Safety, and Immunogenicity of an Enterovirus 71 Vaccine in China Fengcai Zhu, Wenbo Xu, Jielai Xia, New England Journal of Medicine	2014	458
An Inactivated Enterovirus 71 Vaccine in Healthy Children Rongcheng Li, Longding Liu, Zhaojun Mo, New England Journal of Medicine	2014	395
A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71 Xiangxi Wang, Wei Peng, Jingshan Ren, Nature Structural & Molecular Biology Virus StructureMolecular VirologyPathogenesisSensor-adaptor MechanismVirology	2012	390
Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial Xiaofeng Liang, Huaqing Wang, Junzhi Wang, The Lancet VaccinationVaccine SafetyCross-protectionInternational HealthPlacebo-controlled Trial	2009	254
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial Fengcai Zhu, Alie Wurie, Lihua Hou, The Lancet VaccinationVaccine SafetyVaccine DevelopmentVaccine EfficacySierra Leone	2016	198
Hepatitis A virus and the origins of picornaviruses Xiangxi Wang, Jingshan Ren, Qiang Gao, Nature HepatitisVirologyVirus ClassificationVirus PhylogenyMedicine	2014	194
Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial Fengcai Zhu, Lihua Hou, Jingxin Li, The Lancet VaccinationVaccine SafetyVaccine DevelopmentPreliminary ReportImmunology	2015	187
Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial You‐Lin Qiao, Ting Wu, Rongcheng Li, JNCI Journal of the National Cancer Institute	2019	172
Picornavirus uncoating intermediate captured in atomic detail Jingshan Ren, Xiangxi Wang, Zhongyu Hu, Nature Communications	2013	164
Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates Qian He, Qunying Mao, Chaoqiang An, Emerging Microbes & Infections VaccinationVaccine DevelopmentMedicineVaccine SurveillanceVaccine Target	2021	164

Page 1